Matt Vanderhoek, Ph.D. - Publications

Affiliations: 
2011 University of Wisconsin, Madison, Madison, WI 
Area:
Medical Biophysics, Radiology

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Vanderhoek M, Perlman SB, Jeraj R. Impact of different standardized uptake value measures on PET-based quantification of treatment response. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1188-94. PMID 23776199 DOI: 10.2967/Jnumed.112.113332  0.662
2012 Vanderhoek M, Perlman SB, Jeraj R. Impact of the definition of peak standardized uptake value on quantification of treatment response. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 4-11. PMID 22213818 DOI: 10.2967/Jnumed.111.093443  0.639
2012 Scully P, Vanderhoek M, Perlman S, Liu G, Jeraj R. WE-C-BRA-07: Assessment of Heterogeneous Treatment Response in Patients with Multiple Solid Tumors Medical Physics. 39: 3948-3948. DOI: 10.1118/1.4736112  0.634
2011 Chao BH, Harrison MR, Kolesar J, Vanderhoek M, Perlman S, Eickhoff JC, Carmichael L, Alberti DB, Wilding G, Jeraj R, Liu G. Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e13556. PMID 28022757 DOI: 10.1200/Jco.2011.29.15_Suppl.E13556  0.552
2011 Liu G, Jeraj R, Vanderhoek M, Perlman S, Kolesar J, Harrison M, Simoncic U, Eickhoff J, Carmichael L, Chao B, Marnocha R, Ivy P, Wilding G. Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7634-44. PMID 22038997 DOI: 10.1158/1078-0432.Ccr-11-1677  0.602
2011 Vanderhoek M, Juckett MB, Perlman SB, Nickles RJ, Jeraj R. Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging. Leukemia Research. 35: 310-6. PMID 20832860 DOI: 10.1016/J.Leukres.2010.06.010  0.666
2011 Scully P, Jallow N, Vanderhoek M, Jeraj R. SU-E-J-87: Imaging Biomarkers of Treatment Response: A Roadmap to Validation Medical Physics. 38: 3462-3462. DOI: 10.1118/1.3611855  0.724
2011 Jallow N, Scully P, Vanderhoek M, Perlman S, Liu G, Jeraj R. SU-E-I-176: Impact of Residual Activity and Clock Synchronization on Quantitative Treatment Response Assessment Medical Physics. 38: 3437-3437. DOI: 10.1118/1.3611750  0.758
2011 Vanderhoek M, Perlman S, Jeraj R. SU-E-I-167: Impact of Peak SUV Definition on Quantification of Treatment Response Medical Physics. 38: 3434-3435. DOI: 10.1118/1.3611741  0.653
2010 Harrison MR, Jeraj R, Vanderhoek M, Simoncic U, Perlman S, Kolesar J, Eickhoff JC, Alberti DB, Wilding G, Liu G. Characterization of proliferative rebound during drug holiday by FLT-PET imaging in patients treated with sunitinib (SU). Journal of Clinical Oncology. 28: 3094-3094. DOI: 10.1200/Jco.2010.28.15_Suppl.3094  0.537
2010 Jeraj R, Liu G, Simoncic U, Vanderhoek M, Perlman S, Alberti DB, Harrison MR, Wilding G. Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI. Journal of Clinical Oncology. 28: 3050-3050. DOI: 10.1200/Jco.2010.28.15_Suppl.3050  0.513
2010 Titz B, Vanderhoek M, Simoncic U, Adhikarla V, Jeraj R. MO-E-BRB-05: A Computational Tumor Modeling Framework for the Optimization of Molecular Targeted Therapies Medical Physics. 37: 3356-3356. DOI: 10.1118/1.3469115  0.715
2010 Morrison C, Vanderhoek M, Perlman S, Jeraj R. MO-D-204B-05: Effect of PET Image Reconstruction Parameters on Quantitative Treatment Response Assessment Medical Physics. 37: 3342-3342. DOI: 10.1118/1.3469066  0.623
2010 Yip S, Vanderhoek M, Jeraj R. SU-GG-J-155: Impact of Deformable-Registration-Based Contour Propagation on PET Based Treatment Response Assessment Medical Physics. 37: 3181-3181. DOI: 10.1118/1.3468379  0.635
2010 Vanderhoek M, Lawrence J, Vail D, Jeraj R. SU-GG-J-151: Intra-Patient Response Heterogeneity Using FLT PET during Chemotherapy in Canine Subjects with Lymphoma Medical Physics. 37: 3180-3180. DOI: 10.1118/1.3468374  0.63
2009 Lawrence J, Vanderhoek M, Barbee D, Jeraj R, Tumas DB, Vail DM. Use of 3'-deoxy-3'-[18F]fluorothymidine PET/CT for evaluating response to cytotoxic chemotherapy in dogs with non-Hodgkin's lymphoma. Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 50: 660-8. PMID 19999354 DOI: 10.1111/J.1740-8261.2009.01612.X  0.603
2009 Vail DM, Thamm DH, Reiser H, Ray AS, Wolfgang GH, Watkins WJ, Babusis D, Henne IN, Hawkins MJ, Kurzman ID, Jeraj R, Vanderhoek M, Plaza S, Anderson C, Wessel MA, et al. Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3503-10. PMID 19417014 DOI: 10.1158/1078-0432.Ccr-08-3113  0.525
2009 Jeraj R, Vanderhoek M, Simoncic U, Perlman S, Alberti D, Wilding G, Liu G. WE-C-BRC-05: Use of FLT PET Imaging to Assess Tyrosine Kinase Inhibitor (TKI) Treatment Response Medical Physics. 36: 2761-2761. DOI: 10.1118/1.3182473  0.633
2009 Vanderhoek M, Perlman S, Liu G, Jeraj R. WE-C-BRC-04: Predictive Power of Various PET Measures for Treatment Response Assessment Medical Physics. 36: 2761-2761. DOI: 10.1118/1.3182472  0.639
2009 Jallow N, Vanderhoek M, Barbee D, Song C, Jeraj R. SU-FF-J-142: Sensitivity of Treatment Assessment to Different PET Normalization Techniques Medical Physics. 36: 2509-2509. DOI: 10.1118/1.3181434  0.753
2008 Liu G, Jeraj R, Perlman S, Vanderhoek M, Kolesar J, Eickhoff J, Alberti D, Wilding G. Pharmacodynamic study of FLT-PET imaging in patients treated with sunitinib. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3515. PMID 27949756 DOI: 10.1200/Jco.2008.26.15_Suppl.3515  0.586
2008 Juckett MB, Vanderhoek M, Perlman S, Nickles R, Jeraj R. A Pilot Study for Using 3′-Deoxy-3′-[ 18 f]Fluorothymidine Positron Emission Tomography ([18F]FLT PET/CT) Imaging for Early Assessment of Response to Induction Chemotherapy in Acute Myeloid Leukemia (AML) Blood. 112: 2550-2550. DOI: 10.1182/Blood.V112.11.2550.2550  0.645
2008 Vanderhoek M, Juckett M, Nickles R, Jeraj R. TH-D-AUD C-06: Early Assessment of Treatment Response in Hematopoietic Disease Using [18F]FLT PET Imaging Medical Physics. 35: 2987-2987. DOI: 10.1118/1.2962918  0.59
2007 Vanderhoek M, Barbee D, Jeraj R. TH-D-M100J-09: Activity Recovery From Dual Radiotracer PET Scans Medical Physics. 34: 2640-2640. DOI: 10.1118/1.2761718  0.586
2006 Vanderhoek M, Pyzalski R, Jaskowiak C, Jeraj R. TH-E-ValB-04: Dosimetric Impact of Changed FLT Uptake in AML Patients Treated with Chemotherapy Medical Physics. 33: 2290-2290. DOI: 10.1118/1.2241944  0.612
Show low-probability matches.